| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1418897A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer |
| 05/19/2004 | EP1418869A1 Kavalactone compositions and methods of use |
| 05/19/2004 | EP1296695B1 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1190716B1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 05/19/2004 | EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0888323B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/19/2004 | CN1498385A Methods and devices for quantitative analysis of x-ray images |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498103A Novel use of peptide class of compound for treating non-neuropathic inflammatory pain |
| 05/19/2004 | CN1496986A Industrial synthetising strontium salt and method of its hydrate |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1496737A Method for treating inflammation of muscular skeleton and connective tissue |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150019C Medicine for treating hecrosis of femoral head |
| 05/19/2004 | CN1150012C Chinese patent medicine for treating hyperosteogeny |
| 05/19/2004 | CN1150007C Externally applied Chinese medicine for rheumatism and asthma |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/19/2004 | CN1150000C Compositions containing diphosphonic acids |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2004039389A1 SELECTIVE HUMAN β3 ADRENALIN RECEPTOR AGONIST AGENT |
| 05/13/2004 | WO2004039313A2 Preventing desensitization of receptors |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004006931A3 Pharmaceutical compostions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2 |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2002038171A9 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091423 Methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or |
| 05/13/2004 | CA2503624A1 Use of a nitric oxide donor to prevent desensitization of g-protein coupled receptors |
| 05/12/2004 | EP1418164A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists |
| 05/12/2004 | EP1417975A1 REMEDIES FOR DISEASES WITH BONE MASS LOSS HAVING EP sb 4 /sb AGONIST AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1417307A2 Oligonucleotide compositions and their use to induce apoptosis |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417201A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416966A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 05/12/2004 | EP1416944A1 Composition for treatment of articular cartilage damage |
| 05/12/2004 | EP1416942A1 Method for treating gout and binding uric acid |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1416887A2 Cartilage repair and regeneration device and method |
| 05/12/2004 | EP1416886A2 Cartilage repair and regeneration scaffold and method |
| 05/12/2004 | EP1416880A2 Cartilage repair apparatus and method |
| 05/12/2004 | EP1416866A2 Devices form naturally occurring biologically derived |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1161410B1 Retinoid antagonists and use thereof |
| 05/12/2004 | EP1156810B1 Solution for injection for the treatment of arthroses |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP1019027A4 Implantable collagen-containing putty material |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 05/12/2004 | CN1496408A Glucosamine and method of making glucosamine from microbial biomass |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |